Yared RA, Chen CC, Vandorpe A, Arvanitakis M, et al. Intravenous Hemin, a potential heme oxygenase-1 activator, does not protect from post-ERCP acute pancreatitis in humans: Results of a randomized multicentric multinational placebo-controlled trial. Pancreatology 2024 Feb 15:S1424-3903(24)00036-X. doi: 10.1016/j.pan.2024.
PMID: 38431445